1 – 20 of 2264
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Treatment with mycophenolate mofetil is associated with improved nailfold vasculature in systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Adherence to dietary guidelines, and the risk of developing rheumatoid arthritis-results from a nested case-control study
(
- Contribution to journal › Article
-
Mark
EULAR recommendations for the management of ANCA-associated vasculitis : 2022 update
(
- Contribution to journal › Article
-
Mark
Inflammatory rheumatic diseases and the risk of drug use disorders: a register-based cohort study in Sweden
(
- Contribution to journal › Article
-
Mark
Evaluation of the ACR/EULAR 2022 criteria for classification of ANCA-associated vasculitis in a population-based cohort from Sweden
(
- Contribution to journal › Article
-
Mark
Joint tenderness at 3 months follow-up better predicts long-term pain than baseline characteristics in early rheumatoid arthritis patients
(
- Contribution to journal › Article
-
Mark
Charles Bonnet Syndrome Adversely Affects Vision-Related Quality of Life in Patients with Glaucoma
(
- Contribution to journal › Article
-
Mark
Person-centred care and preferred outcomes in early rheumatoid arthritis — the patients’ perspective
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Remission and low disease activity are associated with lower healthcare costs : results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort
2024) In Annals of the Rheumatic Diseases(
- Contribution to journal › Article
-
Mark
Rheumatic and Musculoskeletal Diseases and Risk of Dementia : A Nested Case-Control Study
(
- Contribution to journal › Article
-
Mark
2023 EULAR classification criteria for hand osteoarthritis
2024) In Annals of the Rheumatic Diseases(
- Contribution to journal › Article
-
Mark
A comparative study of fatigue and processing speed in patients with multiple sclerosis treated with natalizumab or rituximab
(
- Contribution to journal › Article
-
Mark
Serum ARGS-aggrecan in a phase 2 clinical trial targeting osteoarthritis
(
- Contribution to journal › Article
-
Mark
Mortality Rate by Diagnosis in ANCA-Associated Vasculitis Across FAIRVASC Registries
2024) p.187-187(
- Contribution to conference › Abstract
-
Mark
Drug exposure and subsequent diagnosis with ANCA-associated vasculitis – A population-based case- control study
2024) p.191-191(
- Contribution to conference › Abstract
-
Mark
Temporal clustering of ANCA-associated vasculitis occurrence
2024) p.471-471(
- Contribution to conference › Abstract
-
Mark
Frequent use of prescription NSAIDs among people with knee or hip osteoarthritis despite contraindications to or precautions with NSAIDs
2024) In Osteoarthritis and Cartilage(
- Contribution to journal › Article
-
Mark
Prescription of non-steroidal anti-inflammatory drugs for patients with inflammatory arthritis decreases with the initiation of tumour necrosis factor inhibitor therapy : results from the ICEBIO registry
2024) In Scandinavian Journal of Rheumatology(
- Contribution to journal › Article
-
Mark
Apolipoproteins and the risk of giant cell arteritis—a nested case–control study
(
- Contribution to journal › Article
-
Mark
Cartilage destruction in early rheumatoid arthritis patients correlates with CD21−/low double-negative B cells
(
- Contribution to journal › Article